Rossmore Private Capital Bio Techne Corp Transaction History

Rossmore Private Capital

  • $798 Million
  • Q4 2024

A detailed history of Rossmore Private Capital transactions in Bio Techne Corp stock. As of the latest transaction made, Rossmore Private Capital holds 4,000 shares of TECH stock, worth $234,920. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,000 -0.0%
Holding current value
$234,920
Previous $319,000 9.72%
% of portfolio
0.04%
Previous 0.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$80.67 - $352.29 $242,010 - $1.06 Million
3,000 Added 300.0%
4,000 $331,000
Q2 2020

Aug 05, 2020
BUY
$185.43 - $279.56 $185,430 - $279,560
1,000 New
1,000 $264,000
Q1 2020

May 07, 2020
SELL
$161.17 - $221.51 $161,170 - $221,510
-1,000 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$189.68 - $222.09 $189,680 - $222,090
1,000 New
1,000 $220,000
Q3 2019

Nov 05, 2019
SELL
$183.56 - $216.72 $183,560 - $216,720
-1,000 Closed
0 $0
Q2 2019

Aug 05, 2019
BUY
$188.72 - $215.43 $188,720 - $215,430
1,000 New
1,000 $208,000
Q4 2018

Jan 22, 2019
SELL
$132.75 - $203.8 $132,750 - $203,800
-1,000 Closed
0 $0
Q3 2018

Oct 26, 2018
BUY
$147.44 - $204.11 $147,440 - $204,110
1,000 New
1,000 $204,000
Q1 2018

May 04, 2018
SELL
$131.46 - $151.04 $131,460 - $151,040
-1,000 Closed
0 $0
Q4 2017

Mar 15, 2018
BUY
$121.17 - $134.75 $121,170 - $134,750
1,000
1,000 $130 Million

Others Institutions Holding TECH

# of Institutions
617
Shares Held
154M
Call Options Held
161K
Put Options Held
12.7K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.3B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email